Irak inhibitor and preparation method therefor and use thereof

Irak inhibitor and preparation method therefor and use thereof

Disclosed is a compound represented by formula I, a stereoisomer, racemate, tautomer, isotopic label, prodrug thereof or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising same, a preparation method therefor, and medical use thereof. The structure is as shown in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: HE Qian, DING Yawen, YE Guozhong, DING Chenli, WANG Chaodong
Format: Patent
Sprache:eng ; heb
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator HE Qian
DING Yawen
YE Guozhong
DING Chenli
WANG Chaodong
description Disclosed is a compound represented by formula I, a stereoisomer, racemate, tautomer, isotopic label, prodrug thereof or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising same, a preparation method therefor, and medical use thereof. The structure is as shown in formula I.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_IL291158A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>IL291158A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_IL291158A3</originalsourceid><addsrcrecordid>eNrjZLDzLErMVsjMy8hMyizJL1JIzEtRKChKLUgsSizJzM9TyE0tychPUSjJSC1KTYPKlxanQgTy03gYWNMSc4pTeaE0N4Ocm2uIs4duakF-fGpxQWJyal5qSbynj5GloaGphaMxQQUASDMvbw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Irak inhibitor and preparation method therefor and use thereof</title><source>esp@cenet</source><creator>HE Qian ; DING Yawen ; YE Guozhong ; DING Chenli ; WANG Chaodong</creator><creatorcontrib>HE Qian ; DING Yawen ; YE Guozhong ; DING Chenli ; WANG Chaodong</creatorcontrib><description>Disclosed is a compound represented by formula I, a stereoisomer, racemate, tautomer, isotopic label, prodrug thereof or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising same, a preparation method therefor, and medical use thereof. The structure is as shown in formula I.</description><language>eng ; heb</language><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220501&amp;DB=EPODOC&amp;CC=IL&amp;NR=291158A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220501&amp;DB=EPODOC&amp;CC=IL&amp;NR=291158A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HE Qian</creatorcontrib><creatorcontrib>DING Yawen</creatorcontrib><creatorcontrib>YE Guozhong</creatorcontrib><creatorcontrib>DING Chenli</creatorcontrib><creatorcontrib>WANG Chaodong</creatorcontrib><title>Irak inhibitor and preparation method therefor and use thereof</title><description>Disclosed is a compound represented by formula I, a stereoisomer, racemate, tautomer, isotopic label, prodrug thereof or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising same, a preparation method therefor, and medical use thereof. The structure is as shown in formula I.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLDzLErMVsjMy8hMyizJL1JIzEtRKChKLUgsSizJzM9TyE0tychPUSjJSC1KTYPKlxanQgTy03gYWNMSc4pTeaE0N4Ocm2uIs4duakF-fGpxQWJyal5qSbynj5GloaGphaMxQQUASDMvbw</recordid><startdate>20220501</startdate><enddate>20220501</enddate><creator>HE Qian</creator><creator>DING Yawen</creator><creator>YE Guozhong</creator><creator>DING Chenli</creator><creator>WANG Chaodong</creator><scope>EVB</scope></search><sort><creationdate>20220501</creationdate><title>Irak inhibitor and preparation method therefor and use thereof</title><author>HE Qian ; DING Yawen ; YE Guozhong ; DING Chenli ; WANG Chaodong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_IL291158A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; heb</language><creationdate>2022</creationdate><toplevel>online_resources</toplevel><creatorcontrib>HE Qian</creatorcontrib><creatorcontrib>DING Yawen</creatorcontrib><creatorcontrib>YE Guozhong</creatorcontrib><creatorcontrib>DING Chenli</creatorcontrib><creatorcontrib>WANG Chaodong</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HE Qian</au><au>DING Yawen</au><au>YE Guozhong</au><au>DING Chenli</au><au>WANG Chaodong</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Irak inhibitor and preparation method therefor and use thereof</title><date>2022-05-01</date><risdate>2022</risdate><abstract>Disclosed is a compound represented by formula I, a stereoisomer, racemate, tautomer, isotopic label, prodrug thereof or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising same, a preparation method therefor, and medical use thereof. The structure is as shown in formula I.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; heb
recordid cdi_epo_espacenet_IL291158A
source esp@cenet
title Irak inhibitor and preparation method therefor and use thereof
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T04%3A41%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HE%20Qian&rft.date=2022-05-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EIL291158A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true